Literature DB >> 25027822

Secondary bacterial infections in influenza virus infection pathogenesis.

Amber M Smith1, Jonathan A McCullers.   

Abstract

Influenza is often complicated by bacterial pathogens that colonize the nasopharynx and invade the middle ear and/or lung epithelium. Incidence and pathogenicity of influenza-bacterial coinfections are multifactorial processes that involve various pathogenic virulence factors and host responses with distinct site- and strain-specific differences. Animal models and kinetic models have improved our understanding of how influenza viruses interact with their bacterial co-pathogens and the accompanying immune responses. Data from these models indicate that considerable alterations in epithelial surfaces and aberrant immune responses lead to severe inflammation, a key driver of bacterial acquisition and infection severity following influenza. However, further experimental and analytical studies are essential to determining the full mechanistic spectrum of different viral and bacterial strains and species and to finding new ways to prevent and treat influenza-associated bacterial coinfections. Here, we review recent advances regarding transmission and disease potential of influenza-associated bacterial infections and discuss the current gaps in knowledge.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25027822      PMCID: PMC7122299          DOI: 10.1007/82_2014_394

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  168 in total

1.  Prevalence of PB1-F2 of influenza A viruses.

Authors:  Roland Zell; Andi Krumbholz; Annett Eitner; Reimar Krieg; Karl-Jürgen Halbhuber; Peter Wutzler
Journal:  J Gen Virol       Date:  2007-02       Impact factor: 3.891

2.  The effects of influenza A virus PB1-F2 protein on polymerase activity are strain specific and do not impact pathogenesis.

Authors:  Julie L McAuley; Kelly Zhang; Jonathan A McCullers
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  Sialidase (neuraminidase) activity among gram-negative anaerobic and capnophilic bacteria.

Authors:  B J Moncla; P Braham; S L Hillier
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

4.  Effect of influenza A virus infection on nasopharyngeal colonization and otitis media induced by transparent or opaque phenotype variants of Streptococcus pneumoniae in the chinchilla model.

Authors:  H H Tong; J N Weiser; M A James; T F DeMaria
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

5.  Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets.

Authors:  Jonathan A McCullers; Julie L McAuley; Sarah Browall; Amy R Iverson; Kelli L Boyd; Birgitta Henriques Normark
Journal:  J Infect Dis       Date:  2010-10-15       Impact factor: 5.226

6.  Hypersusceptibility to invasive pneumococcal infection in experimental sickle cell disease involves platelet-activating factor receptor.

Authors:  Martha L Miller; Geli Gao; Tamara Pestina; Derek Persons; Elaine Tuomanen
Journal:  J Infect Dis       Date:  2007-01-08       Impact factor: 5.226

7.  Naturally occurring swine influenza A virus PB1-F2 phenotypes that contribute to superinfection with Gram-positive respiratory pathogens.

Authors:  Jenni N Weeks-Gorospe; Heather R Hurtig; Amy R Iverson; Margaret J Schuneman; Richard J Webby; Jonathan A McCullers; Victor C Huber
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

8.  Improving therapeutic strategies for secondary bacterial pneumonia following influenza.

Authors:  Jonathan A McCullers; B Keith English
Journal:  Future Microbiol       Date:  2008-08       Impact factor: 3.165

9.  Lowering the threshold of lung innate immune cell activation alters susceptibility to secondary bacterial superinfection.

Authors:  John Goulding; Alexandra Godlee; Seema Vekaria; Markus Hilty; Robert Snelgrove; Tracy Hussell
Journal:  J Infect Dis       Date:  2011-10-01       Impact factor: 5.226

10.  Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae.

Authors:  Kirsty R Short; Patrick C Reading; Nancy Wang; Dimitri A Diavatopoulos; Odilia L Wijburg
Journal:  MBio       Date:  2012-09-25       Impact factor: 7.867

View more
  48 in total

1.  Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa.

Authors:  Timothy M Uyeki; Henry H Bernstein; John S Bradley; Janet A Englund; Thomas M File; Alicia M Fry; Stefan Gravenstein; Frederick G Hayden; Scott A Harper; Jon Mark Hirshon; Michael G Ison; B Lynn Johnston; Shandra L Knight; Allison McGeer; Laura E Riley; Cameron R Wolfe; Paul E Alexander; Andrew T Pavia
Journal:  Clin Infect Dis       Date:  2019-03-05       Impact factor: 9.079

Review 2.  The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.

Authors:  Amber M Smith; Victor C Huber
Journal:  Viral Immunol       Date:  2017-11-17       Impact factor: 2.257

3.  Lethal coinfection of influenza virus and Streptococcus pneumoniae lowers antibody response to influenza virus in lung and reduces numbers of germinal center B cells, T follicular helper cells, and plasma cells in mediastinal lymph Node.

Authors:  Yuet Wu; Wenwei Tu; Kwok-Tai Lam; Kin-Hung Chow; Pak-Leung Ho; Yi Guan; Joseph S Malik Peiris; Yu-Lung Lau
Journal:  J Virol       Date:  2014-11-26       Impact factor: 5.103

4.  Heterotypic Influenza Infections Mitigate Susceptibility to Secondary Bacterial Infection.

Authors:  Ellyse M Cipolla; Molin Yue; Kara L Nickolich; Brydie R Huckestein; Danielle Antos; Wei Chen; John F Alcorn
Journal:  J Immunol       Date:  2022-08-01       Impact factor: 5.426

5.  Time-Dependent Increase in Susceptibility and Severity of Secondary Bacterial Infections During SARS-CoV-2.

Authors:  Amanda P Smith; Evan P Williams; Taylor R Plunkett; Muneeswaran Selvaraj; Lindey C Lane; Lillian Zalduondo; Yi Xue; Peter Vogel; Rudragouda Channappanavar; Colleen B Jonsson; Amber M Smith
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

Review 6.  Influenza virus replication in macrophages: balancing protection and pathogenesis.

Authors:  Troy D Cline; Donald Beck; Elizabeth Bianchini
Journal:  J Gen Virol       Date:  2017-09-08       Impact factor: 3.891

7.  A Murine Model for Enhancement of Streptococcus pneumoniae Pathogenicity upon Viral Infection and Advanced Age.

Authors:  Basma H Joma; Nalat Siwapornchai; Vijay K Vanguri; Anishma Shrestha; Sara E Roggensack; Bruce A Davidson; Albert K Tai; Anders P Hakansson; Simin N Meydani; John M Leong; Elsa N Bou Ghanem
Journal:  Infect Immun       Date:  2021-07-15       Impact factor: 3.441

Review 8.  Intranasal Vaccine Delivery Technology for Respiratory Tract Disease Application with a Special Emphasis on Pneumococcal Disease.

Authors:  William Walkowski; Justin Bassett; Manmeet Bhalla; Blaine A Pfeifer; Elsa N Bou Ghanem
Journal:  Vaccines (Basel)       Date:  2021-06-02

Review 9.  Best practice assessment of disease modelling for infectious disease outbreaks.

Authors:  Z F Dembek; T Chekol; A Wu
Journal:  Epidemiol Infect       Date:  2018-05-08       Impact factor: 4.434

10.  Effect of Vitamin A Deficiency in Dysregulating Immune Responses to Influenza Virus and Increasing Mortality Rates After Bacterial Coinfections.

Authors:  Rhiannon R Penkert; Amanda P Smith; Eike R Hrincius; Jonathan A McCullers; Peter Vogel; Amber M Smith; Julia L Hurwitz
Journal:  J Infect Dis       Date:  2021-05-28       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.